VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,764,643 | -4.7% | 962,493 | +47.8% | 0.03% | 0.0% |
| Q2 2023 | $15,491,548 | -3.2% | 651,179 | +3.5% | 0.03% | -11.8% |
| Q1 2023 | $16,009,901 | -10.4% | 629,320 | +2.9% | 0.03% | -15.0% |
| Q4 2022 | $17,860,658 | +43.1% | 611,457 | +0.5% | 0.04% | +48.1% |
| Q3 2022 | $12,483,000 | +142.6% | 608,662 | +36.8% | 0.03% | +145.5% |
| Q2 2022 | $5,145,000 | +1478.2% | 444,799 | +2432.6% | 0.01% | +1000.0% |
| Q1 2022 | $326,000 | -81.4% | 17,563 | -80.1% | 0.00% | -66.7% |
| Q4 2021 | $1,748,000 | – | 88,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |